🇺🇸 FDA
Patent

US 6753317

Dmt-Tic di- and tri-peptide derivatives and related compositions and methods of use

expired A61KA61K38/00

Quick answer

US patent 6753317 (Dmt-Tic di- and tri-peptide derivatives and related compositions and methods of use) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jun 22 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00